Japan’s catheter ablation activity expands across a decade of hospital data
A nationwide hospital-level analysis in Japan traced the growth of catheter ablation activity across fiscal years 2014 through 2024 and did so without relying on sampling or facility consent. By drawing on every Diagnosis Procedure Combination participating hospital, the study captured a broader picture of procedural activity than the national voluntary registry could provide. The result is a long view of how an interventional electrophysiology procedure moved through the country’s hospital system, not as a static annual count but as a changing network of centers entering, exiting, and expanding over time.
The study’s structure matters because catheter ablation is a procedure whose real-world growth depends on more than clinical demand alone. It requires trained operators, institutional equipment, referral pathways, and a system capable of absorbing procedural volume year after year. Tracking activity at the facility level across 11 years makes it possible to see whether national expansion came mostly from established hospitals doing more cases, from new hospitals joining the field, or from a combination of both. The analysis was built to separate those forces rather than blur them into one national trend line.
Facility-level growth, not just a national total
An 11-year panel of hospitals was assembled through record linkage that relied on continuity of registry numbers, locations, and case volumes. That design allowed investigators to follow hospitals over time and identify facility dynamics, including entry and exit from the ablation landscape. Growth accounting then decomposed the net increase in national volume into three components: volume growth at existing facilities, entry, and exit. This is a rare way to study procedural diffusion because it does not stop at asking whether the total number of ablations went up. It asks where the growth came from.
The decomposition was complete by construction, meaning the entire national change could be assigned to those components. In practical terms, that gives hospital leaders and health systems a framework for understanding how interventional capacity spreads. A rising national total can reflect consolidation in a few high-volume centers, broadening access across a larger number of hospitals, or some shifting mix of both. For catheter ablation, where procedural expertise and referral volume are closely linked, those patterns can carry implications for workforce planning and service distribution.
One immediate inference is unavoidable: Japan’s procedural expansion was not a simple story of a fixed set of hospitals doing a little more work. The hospital network itself changed.
What the database could capture, and what it could not
The study’s strengths are substantial, but so are its boundaries. Annual case counts below 10 are suppressed in the DPC open database, so the definition of entry and exit necessarily includes facilities whose volume crossed that reporting threshold. Non-DPC facilities are excluded entirely. Those features make the national estimate powerful, yet still incomplete in a specific and transparent way. Small-volume practice sites may be underrepresented, and any institution outside the DPC system sits beyond the frame.
The database also contained no information on target arrhythmias, complications, procedural outcomes, or operators. That omission sharply limits any attempt to translate volume growth into quality growth. A rising number of ablations does not tell clinicians whether the procedures were performed for atrial fibrillation, supraventricular tachycardia, or another rhythm disorder. It does not reveal whether complication rates improved, whether repeat procedures fell, or whether procedural success differed by hospital type. Without operator-level data, the study cannot address whether expansion was accompanied by skill concentration or diffusion.
Those missing elements are not minor footnotes. They define the edge of the evidence. Volume is a useful marker of procedural adoption, but in electrophysiology it is only one part of the clinical picture. High-volume growth can signal stronger access to care, yet it can also hide uneven case mix, varying technical complexity, and unknown outcome gradients across institutions.
Why the growth accounting approach matters for electrophysiology services
For a procedure such as catheter ablation, growth accounting offers a clearer lens than a single annual tally. Existing centers may absorb rising demand as referral networks mature and experience accumulates. New centers may emerge as equipment, expertise, and institutional investment spread. Some facilities may also disappear from the procedural map once activity drops below the reporting threshold or institutional priorities change. Each of those patterns has different implications for patient access and system capacity.
Hospital activity data of this kind are especially relevant in a field where procedural volume often tracks specialization. Ablation programs are not interchangeable from one hospital to the next. They depend on a clinical ecosystem that includes diagnostics, anesthesia support, follow-up care, and the ability to manage complications when they occur. A hospital-level panel can therefore show more than administrative growth; it can map the maturation of a procedural service line across an entire national system.
In that sense, the study captures a structural shift in how arrhythmia care is delivered. More hospitals appear to have become active players, and existing centers appear to have handled more procedures over time. The national total rose through both pathways. For policy and service planning, that matters because the drivers of growth determine where future bottlenecks are likely to appear.
The unresolved clinical questions behind a rising procedural total
The study offers no direct answer to whether more ablation activity translated into better arrhythmia control, fewer hospitalizations, or fewer drug-related adverse effects. It also cannot show whether rising volume reflected changing indications, more complex patients, or a broader willingness to refer patients for invasive rhythm control. Without arrhythmia-specific data, the clinical meaning of the growth remains partly inferential.
A procedural count can also move for reasons that have little to do with disease burden. Reimbursement policy, referral behavior, institutional competition, and equipment access can all influence whether a patient is treated in a given hospital and whether that hospital remains active over time. Those forces are invisible in the open database used here, yet they are central to understanding why catheter ablation expanded so quickly across the decade.
What this study does establish is the scale and shape of the expansion itself. Japan’s nationwide hospital data show a growing procedural footprint for catheter ablation, with growth spread across both established and newly active facilities. The missing outcome data leave the next question unanswered: whether this expansion was matched by measurable gains in safety, efficacy, and equity of access across arrhythmia care.